RT Journal Article
SR Electronic
T1 Easing social distancing index after COVID-19 pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.11.20128165
DO 10.1101/2020.06.11.20128165
A1 Chen, Sam Li-Sheng
A1 Yen, Amy Ming-Fang
A1 Lai, Chao-Chih
A1 Hsu, Chen-Yang
A1 Chen, Hsiu-Hsi
YR 2020
UL http://medrxiv.org/content/early/2020/06/12/2020.06.11.20128165.abstract
AB Context Easing social distancing (ESD) is a global public health issue in post-pandemic period of COVID-19 and requires a simple index for real time assessment.Objective We aimed to develop a simple index for ESD to quantify the impacts of social distancing for reducing confirmed infected cases, optimal triage and care of patients for recovery, and critical care capacity for reducing death from COVID-19.Design, Setting, and Participants Data on the retrospective cohort of 185 countries with reported numbers on confirmed cases, recovery, and death from COVID-19 were retrieved from publicity available repository. Up to May 31, a total of 5,844,136 confirmed cases, 2,639,961 recovered, and 327,487 deaths were reported globally.Main Outcome Measures The ESD index measured by cumulative number of COVID-19 cases and recovery and case-fatality rate.Results We developed a simple index for the guidance of easing social distancing (ESD). If the ESD index is less than 1, ESD would be considered. The global ESD index declined from 3.87 at peak in March to 1.35 by the end of May, consisting of 56.76% countries/regions (105/185) with the ESD lower than one.Conclusion and Relevance This simple ESD index provides a quantitative assessment on whether and when to ease social distancing from local to global community.Competing Interest StatementThe authors have declared no competing interest.Funding StatementMinistry of Science and Technology, Taiwan (MOST 108-2118-M-002-002-MY3; MOST 108-2118-M-038-001-MY3; MOST 108-2118-M-038-002-MY3). The funders had no role in study design, data collection, analysis, and reporting.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available from the authors.